SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-002966
Filing Date
2021-03-15
Accepted
2021-03-15 08:05:42
Documents
14
Period of Report
2021-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20210311x8k.htm   iXBRL 8-K 35650
2 GRAPHIC ardx-20210311x8k001.jpg GRAPHIC 2284
  Complete submission text file 0001558370-21-002966.txt   194594

Data Files

Seq Description Document Type Size
3 EX-101.SCH ardx-20210311.xsd EX-101.SCH 3257
4 EX-101.DEF ardx-20210311_def.xml EX-101.DEF 13334
5 EX-101.LAB ardx-20210311_lab.xml EX-101.LAB 19787
6 EX-101.PRE ardx-20210311_pre.xml EX-101.PRE 13680
7 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20210311x8k_htm.xml XML 6505
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 21739889
SIC: 2834 Pharmaceutical Preparations